Twin City Private Wealth LLC purchased a new position in shares of Amrize Ltd (NYSE:AMRZ – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 9,969 shares of the company’s stock, valued at approximately $558,000.
Other hedge funds have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC lifted its position in shares of Amrize by 4.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 4,601,319 shares of the company’s stock worth $255,051,000 after buying an additional 214,393 shares during the last quarter. Savvy Advisors Inc. acquired a new position in Amrize during the fourth quarter worth about $1,960,000. J. Safra Sarasin Holding AG raised its stake in Amrize by 31.3% during the fourth quarter. J. Safra Sarasin Holding AG now owns 112,250 shares of the company’s stock worth $6,174,000 after acquiring an additional 26,755 shares in the last quarter. Cannell & Spears LLC bought a new position in shares of Amrize in the third quarter worth about $53,387,000. Finally, Gamco Investors INC. ET AL boosted its stake in shares of Amrize by 108.0% in the 3rd quarter. Gamco Investors INC. ET AL now owns 83,999 shares of the company’s stock valued at $4,076,000 after purchasing an additional 43,615 shares in the last quarter.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on AMRZ shares. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Amrize in a report on Monday, June 22nd. JPMorgan Chase & Co. boosted their price objective on Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a research report on Thursday, March 5th. Truist Financial lowered their target price on Amrize from $75.00 to $65.00 and set a “buy” rating for the company in a report on Friday, May 1st. Oppenheimer set a $68.00 target price on Amrize in a research report on Friday, May 1st. Finally, Citigroup cut their price target on Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $64.71.
Amrize Price Performance
Shares of NYSE AMRZ opened at $52.73 on Thursday. The firm has a fifty day simple moving average of $53.40 and a 200 day simple moving average of $55.66. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $29.17 billion and a PE ratio of 25.23.
Amrize (NYSE:AMRZ – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The business had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. The business’s revenue for the quarter was up 4.7% on a year-over-year basis. On average, sell-side analysts forecast that Amrize Ltd will post 2.75 EPS for the current year.
Amrize Cuts Dividend
The business also recently disclosed a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio is 21.05%.
Insider Transactions at Amrize
In other news, CTO Roald Brouwer acquired 1,500 shares of the firm’s stock in a transaction dated Thursday, May 21st. The stock was purchased at an average price of $49.84 per share, for a total transaction of $74,760.00. Following the completion of the acquisition, the chief technology officer directly owned 19,757 shares in the company, valued at $984,688.88. The trade was a 8.22% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Nollaig Forrest bought 2,000 shares of the stock in a transaction dated Friday, May 22nd. The shares were purchased at an average cost of $50.25 per share, for a total transaction of $100,500.00. Following the completion of the transaction, the insider directly owned 20,139 shares of the company’s stock, valued at $1,011,984.75. This trade represents a 11.03% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 54,920 shares of company stock worth $2,717,429 in the last three months. Insiders own 0.54% of the company’s stock.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Read More
- Five stocks we like better than Amrize
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
